Limitations
obesity, hypogonadism, anemia, CAD, Anemia, diabetes
OBESITY, HYPOGONADISM, ANEMIA, ANEMIA, CAD, DIABETES
This study had several limitations. These findings should not be applied to men who are not hypogonadal, women, transgender and gender diverse people, or to men using supraphysiologic doses of testosterone. Although the TRAVERSE trial’s sample size is to our knowledge the largest of any randomized testosterone trials to date, the sample size of the Anemia Study was defined by the number of randomized participants who had anemia at baseline. The cause of anemia in the enrolled participants was not ascertained. As reported,Participants had high rates of obesity, diabetes, CAD, and other risk factors for CAD because eligibility criteria were designed to enroll men with CAD or increased risk of CAD in addition to meeting the criteria for hypogonadism. Surveys of men with hypogonadism